Oruka Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oruka Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Oruka Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -20.2 %, a 30.8% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Return On Equity for 2023 was -13.8 %, a 38.4% increase from 2022.
  • Oruka Therapeutics, Inc. annual Return On Equity for 2022 was -22.4 %, a 32% increase from 2021.
  • Oruka Therapeutics, Inc. annual Return On Equity for 2021 was -32.9 %, a 4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -13.8 +8.59 +38.4% Jan 1, 2023 Dec 31, 2023
2022 -22.4 +10.5 +32% Jan 1, 2022 Dec 31, 2022
2021 -32.9 +1.37 +4% Jan 1, 2021 Dec 31, 2021
2020 -34.3 +32.3 +48.5% Jan 1, 2020 Dec 31, 2020
2019 -66.6 +28 +29.6% Jan 1, 2019 Dec 31, 2019
2018 -94.6 +34.2 +26.6% Jan 1, 2018 Dec 31, 2018
2017 -129 -71.2 -124% Jan 1, 2017 Dec 31, 2017
2016 -57.6 -23.7 -70% Jan 1, 2016 Dec 31, 2016
2015 -33.9 +19.3 +36.3% Jan 1, 2015 Dec 31, 2015
2014 -53.2 -4.8 -9.91% Jan 1, 2014 Dec 31, 2014
2013 -48.4 +77.5 +61.5% Jan 1, 2013 Dec 31, 2013
2012 -126 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.